Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data

BACKGROUND: The applicability of randomised controlled trials of pharmacological agents to older people with frailty/multimorbidity is often uncertain, due to concerns that trials are not representative. However, assessing trial representativeness is challenging and complex. We explore an approach a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanlon, Peter, Butterly, Elaine, Shah, Anoop S. V., Hannigan, Laurie J., Wild, Sarah H., Guthrie, Bruce, Mair, Frances S., Dias, Sofia, Welton, Nicky J., McAllister, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615407/
https://www.ncbi.nlm.nih.gov/pubmed/36303169
http://dx.doi.org/10.1186/s12916-022-02594-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615407/
https://www.ncbi.nlm.nih.gov/pubmed/36303169
http://dx.doi.org/10.1186/s12916-022-02594-9

Ejemplares similares